Plasma 8-iso-Prostaglandin F2α concentrations and outcomes after acute intracerebral hemorrhage

Clinica Chimica Acta

Volumn 437, Issue , 2014, Pages 141-146

  Du, Quan ^a   Yu, Wen Hua ^a   Dong, Xiao Qiao ^a   Yang, Ding Bo ^a   Shen, Yong Feng ^a   Wang, Hao ^a   Jiang, Li ^a   Du, Yuan Feng ^a   Zhang, Zu Yong ^a   Zhu, Qiang ^a   Che, Zhi Hao ^a   Liu, Qun Jie ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

8 Iso Prostaglandin F2 ; Functional outcome; Intracerebral hemorrhage; Mortality; Oxidative stress; Severity

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; BIOLOGICAL MARKER; PROSTAGLANDIN F2 ALPHA;

AGED; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSTAGLANDIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; ACUTE DISEASE; ANALOGS AND DERIVATIVES; BLOOD; CEREBRAL HEMORRHAGE; FOLLOW UP; MIDDLE AGED; STROKE; TREATMENT OUTCOME; TRENDS;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CEREBRAL HEMORRHAGE; DINOPROST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MORTALITY; STROKE; TREATMENT OUTCOME;

EID: 84910050397     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.07.014     Document Type: Article

References (42)

1. Kitagawa Y. Recent trends in the epidemiology of intracerebral hemorrhage. Circ J 2014, 78:315-317.
2. Bhatia R., Singh H., Singh S., et al. A prospective study of in-hospital mortality and discharge outcome in spontaneous intracerebral hemorrhage. Neurol India 2013, 61:244-248.
3. Aguilar M.I., Freeman W.D. Spontaneous intracerebral hemorrhage. Semin Neurol 2010, 30:555-564.
4. Elijovich L., Patel P.V., Hemphill J.C. Intracerebral hemorrhage. Semin Neurol 2008, 28:657-667.
5. Keep R.F., Xiang J., Ennis S.R., et al. Blood-brain barrier function in intracerebral hemorrhage. Acta Neurochir Suppl 2008, 105:73-77.
6. Wagner K.R. Modeling intracerebral hemorrhage: glutamate, nuclear factor-kappa B signaling and cytokines. Stroke 2007, 38:753-758.
7. Wang X., Mori T., Sumii T., Lo E.H. Hemoglobin-induced cytotoxicity in rat cerebral cortical neurons: caspase activation and oxidative stress. Stroke 2002, 33:1882-1888.
8. Wu H., Wu T., Xu X., Wang J., Wang J. Iron toxicity in mice with collagenase-induced intracerebral hemorrhage. J Cereb Blood Flow Metab 2011, 31:1243-1250.
9. Cherubini A., Ruggiero C., Polidori M.C., Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med 2005, 39:841-852.
10. Wu J., Hua Y., Keep R.F., Schallert T., Hoff J.T., Xi G. Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res 2002, 953:45-52.
11. Peeling J., Yan H.J., Chen S.G., Campbell M., Del Bigio M.R. Protective effects of free radical inhibitors in intracerebral hemorrhage in rat. Brain Res 1998, 795:63-70.
12. Milne G.L., Yin H., Morrow J.D. Human biochemistry of the isoprostane pathway. J Biol Chem 2008, 283:15533-15537.
13. Milne G.L., Yin H., Brooks J.D., Sanchez S., Jackson Roberts L., Morrow J.D. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol 2007, 433:113-126.
14. Liu W., Morrow J.D., Yin H. Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Free Radic Biol Med 2009, 47:1101-1107.
15. Wiswedel I. F(2)-Isoprostanes: sensitive biomarkers of oxidative stress in vitro and in vivo: a gas chromatography-mass spectrometric approach. Methods Mol Biol 2009, 580:3-16.
16. Szułdrzyński K., Zalewski J., Machnik A., Zmudka K. Elevated levels of 8-iso-prostaglandin F2alpha in acute coronary syndromes are associated with systemic and local platelet activation. Pol Arch Med Wewn 2010, 120:19-24.
17. Owczarek D., Cibor D., Mach T. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2010, 16:52-57.
18. Elesber A.A., Best P.J., Lennon R.J., et al. Plasma 8-iso-prostaglandin F2alpha, a marker of oxidative stress, is increased in patients with acute myocardial infarction. Free Radic Res 2006, 40:385-391.
19. Brunetti L., Orlando G., Michelotto B., et al. Identification of 8-iso-prostaglandin F(2alpha) in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. Life Sci 2002, 71:2447-2455.
20. Hoffman S.W., Rzigalinski B.A., Willoughby K.A., Ellis E.F. Astrocytes generate isoprostanes in response to trauma or oxygen radicals. J Neurotrauma 2000, 17:415-420.
21. Basu S., Hellberg A., Ulus A.T., Westman J., Karacagil S. Biomarkers of free radical injury during spinal cord ischemia. FEBS Lett 2001, 508:36-38.
22. Clausen F., Marklund N., Lewén A., Enblad P., Basu S., Hillered L. Interstitial F(2)-isoprostane 8-iso-PGF(2α) as a biomarker of oxidative stress after severe human traumatic brain injury. J Neurotrauma 2012, 29:766-775.
23. Yu G.F., Jie Y.Q., Wu A., Huang Q., Dai W.M., Fan X.F. Increased plasma 8-iso-prostaglandin F2α concentration in severe human traumatic brain injury. Clin Chim Acta 2013, 421:7-11.
24. Du Q., Yang D.B., Shen Y.F., et al. Plasma leptin concentration predicts hematoma growth and early neurological deterioration after acute intracerebral hemorrhage. Peptides 2013, 45:35-39.
25. Kothari R.U., Brott T., Broderick J.P., et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996, 27:1304-1305.
26. Brott T., Broderick J., Kothari R., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997, 28:1-5.
27. van Swieten J.C., Koudstaal P.J., Visser M.C., Schouten H.J., van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19:604-607.
28. Yu W.H., Wang W.H., Dong X.Q., et al. Prognostic significance of plasma copeptin detection compared with multiple biomarkers in intracerebral hemorrhage. Clin Chim Acta 2014, 433:174-178.
29. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet 1994, 344:721-724.
30. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev 2012, 70:257-265.
31. Ji L.L., Gomez-Cabrera M.C., Vina J. Role of free radicals and antioxidant signaling in skeletal muscle health and pathology. Infect Disord Drug Targets 2009, 9:428-444.
32. Köhler A.C., Sag C.M., Maier L.S. Reactive oxygen species and excitation-contraction coupling in the context of cardiac pathology. J Mol Cell Cardiol 2014, 73C:92-102.
33. Woolley J.F., Stanicka J., Cotter T.G. Recent advances in reactive oxygen species measurement in biological systems. Trends Biochem Sci 2013, 38:556-565.
34. Yang Y., Bazhin A.V., Werner J., Karakhanova S. Reactive oxygen species in the immune system. Int Rev Immunol 2013, 32:249-270.
35. Aronowski J., Hall C.E. New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies. Neurol Res 2005, 27:268-279.
36. Wagner K.R., Sharp F.R., Ardizzone T.D., Lu A., Clark J.F. Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 2003, 23:629-652.
37. Wu J., Hua Y., Keep R.F., Nakamura T., Hoff J.T., Xi G. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 2003, 34:2964-2969.
38. Saenger A.K., Christenson R.H. Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem 2010, 56:21-33.
39. Nagayama T., Lan J., Henshall D.C., et al. Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J Neurochem 2000, 75:1716-1728.
40. Sadrzadeh S.M., Anderson D.K., Panter S.S., Hallaway P.E., Eaton J.W. Hemoglobin potentiates central nervous system damage. J Clin Invest 1987, 79:662-664.
41. Alexandrova M.L., Danovska M.P. Serum C-reactive protein and lipid hydroperoxides in predicting short-term clinical outcome after spontaneous intracerebral hemorrhage. J Clin Neurosci 2011, 18:247-252.
42. Chen Y.C., Chen C.M., Liu J.L., Chen S.T., Cheng M.L., Chiu D.T. Oxidative markers in spontaneous intracerebral hemorrhage: leukocyte 8-hydroxyl-2'-deoxyguanosine as an independent predictor of the 30-day outcome. J Neurosurg 2011, 115:1184-1190.